Literature DB >> 28534529

Scientific advice - is drug repurposing missing a trick?

Pan Pantziarka1,2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28534529     DOI： 10.1038/nrclinonc.2017.69

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

Review 1.  Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.

Authors:  P Hadji; R E Coleman; C Wilson; T J Powles; P Clézardin; M Aapro; L Costa; J-J Body; C Markopoulos; D Santini; I Diel; A Di Leo; D Cameron; D Dodwell; I Smith; M Gnant; R Gray; N Harbeck; B Thurlimann; M Untch; J Cortes; M Martin; U-S Albert; P-F Conte; B Ejlertsen; J Bergh; M Kaufmann; I Holen
Journal:  Ann Oncol       Date:  2015-12-17       Impact factor: 32.976

2.  Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency.

Authors:  Jan Regnstrom; Franz Koenig; Bo Aronsson; Tatiana Reimer; Kristian Svendsen; Stelios Tsigkos; Bruno Flamion; Hans-Georg Eichler; Spiros Vamvakas
Journal:  Eur J Clin Pharmacol       Date:  2009-11-20       Impact factor: 2.953

3.  Regulatory watch: Impact of scientific advice from the European Medicines Agency.

Authors:  Matthias P Hofer; Christina Jakobsson; Nikolaos Zafiropoulos; Spiros Vamvakas; Thorsten Vetter; Jan Regnstrom; Robert J Hemmings
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

Review 4.  Drug repurposing in oncology--patient and health systems opportunities.

Authors:  Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

5.  Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.

Authors:  William Chow; Clarissa N Amaya; Steven Rains; Michael Chow; Erin B Dickerson; Brad A Bryan
Journal:  JAMA Dermatol       Date:  2015-11       Impact factor: 10.282

Review 6.  Affordable orphan drugs: a role for not-for-profit organizations.

Authors:  Elin H Davies; Emma Fulton; Daniel Brook; Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2017-02-08       Impact factor: 4.335

7.  Avoidable waste of research related to inadequate methods in clinical trials.

Authors:  Youri Yordanov; Agnes Dechartres; Raphaël Porcher; Isabelle Boutron; Douglas G Altman; Philippe Ravaud
Journal:  BMJ       Date:  2015-03-24

8.  The Repurposing Drugs in Oncology (ReDO) Project.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme; P Vikas
Journal:  Ecancermedicalscience       Date:  2014-07-10

9.  Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.

Authors:  Eddy Pasquier; Nicolas André; Janine Street; Anuradha Chougule; Bharat Rekhi; Jaya Ghosh; Deepa S J Philip; Marie Meurer; Karen L MacKenzie; Maria Kavallaris; Shripad D Banavali
Journal:  EBioMedicine       Date:  2016-02-17       Impact factor: 8.143
  9 in total
  10 in total

Review 1.  Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.

Authors:  Patrycja Nowak-Sliwinska; Leonardo Scapozza; Ariel Ruiz i Altaba
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 2.  Signature-based approaches for informed drug repurposing: targeting CNS disorders.

Authors:  Rammohan Shukla; Nicholas D Henkel; Khaled Alganem; Abdul-Rizaq Hamoud; James Reigle; Rawan S Alnafisah; Hunter M Eby; Ali S Imami; Justin F Creeden; Scott A Miruzzi; Jaroslaw Meller; Robert E Mccullumsmith
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 8.294

Review 3.  Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Authors:  J Javier Hernandez; Michael Pryszlak; Lindsay Smith; Connor Yanchus; Naheed Kurji; Vijay M Shahani; Steven V Molinski
Journal:  Front Oncol       Date:  2017-11-14       Impact factor: 6.244

Review 4.  Overcoming cancer therapeutic bottleneck by drug repurposing.

Authors:  Zhe Zhang; Li Zhou; Na Xie; Edouard C Nice; Tao Zhang; Yongping Cui; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2020-07-02

5.  Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations.

Authors:  Monica M Arroyo; Alberto Berral-González; Santiago Bueno-Fortes; Diego Alonso-López; Javier De Las Rivas
Journal:  Biomolecules       Date:  2020-04-25

6.  Repurposing anthelmintic agents to eradicate resistant leukemia.

Authors:  Caterina Mezzatesta; Liridon Abduli; Anna Guinot; Cornelia Eckert; Denis Schewe; Marketa Zaliova; Luciana Vinti; Blerim Marovca; Yi-Chien Tsai; Silvia Jenni; Julia Aguade-Gorgorio; Arend von Stackelberg; Martin Schrappe; Franco Locatelli; Martin Stanulla; Gunnar Cario; Jean-Pierre Bourquin; Beat C Bornhauser
Journal:  Blood Cancer J       Date:  2020-06-26       Impact factor: 11.037

Review 7.  Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer.

Authors:  Stephanie I Nuñez-Olvera; Dolores Gallardo-Rincón; Jonathan Puente-Rivera; Yarely M Salinas-Vera; Laurence A Marchat; Raúl Morales-Villegas; César López-Camarillo
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

Review 8.  Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.

Authors:  Ping Jin; Jingwen Jiang; Li Zhou; Zhao Huang; Edouard C Nice; Canhua Huang; Li Fu
Journal:  J Hematol Oncol       Date:  2022-07-18       Impact factor: 23.168

9.  Does the oncology community have a rejection bias when it comes to repurposed drugs?

Authors:  Bishal Gyawali; Pan Pantziarka; Sergio Crispino; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2018-01-16

Review 10.  Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.

Authors:  Oana Alexandru; Cristina Horescu; Ani-Simona Sevastre; Catalina Elena Cioc; Carina Baloi; Alexandru Oprita; Anica Dricu
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.